We can do all things but can’t do everything at this moment. Here is where the Synapse Clinical trial leadership will assist and make sure that you buy the highest value solution based on differentiation and value proposition. Our Head Clinical Operation comes with over 25 years’ experience in clinical research industry. Phase I, II, III and patient based pharm kinetic studies in all major therapeutic areas such as Oncology, Psychiatry, Endocrinology, Dermatology, Ophthalmic CVS, CNS, Vaccine studies etc.
He has handled vaccines trials of 12000 Patients. His initiative on Phase III of an approved drug for evaluating efficacy in Novel Corona Virus in Covid-19 patients help the client to receive DCGI approval to market the drug for Covid-19 treatment
Synapse clinical trial team is well versed and experience in most of the therapeutic indications which cater your needs for Phase 1, Phase IIa/Phase IIb and Phase III Study conductions. We believe to conduct your trials with experience hands and ensure to comply with global trial study conductions requirements.
Synapse team is committed to take those consistent actions to build trust among the sponsor, Investigator and the patients. We believe in accomplishing the successful trials as per regulatory requirements and taking 100% ownership of your trials.